Nefextinib is an active pharmaceutical ingredient under investigation in clinical trials for specific oncological research. It is a synthetic compound with a complex heterocyclic structure containing fluorine and ether functional groups.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2070931-57-4
MAX-40279 HEMIFUMARATE
active pharmaceutical ingredient
MAX-40279 hemiadipate
pharmaceutical raw material
Methyl (S)-phenyl[(R)-piperidin-2-yl]acetate
active pharmaceutical ingredient
QUININE SULFATE DIHYDRATE
active pharmaceutical ingredient
Desfesoterodine
Active pharmaceutical ingredient metabolite
Propofol
intravenous anaesthetic and sedative
7-(4-fluoro-2-methoxyphenyl)-6-methyl-N-(1-piperidin-4-ylpyrazol-4-yl)thieno[3,2-d]pyrimidin-2-amine
AVIOBQFPAGEICQ-UHFFFAOYSA-N
CC1=C(C2=NC(=NC=C2S1)NC3=CN(N=C3)C4CCNCC4)C5=C(C=C(C=C5)F)OC